BMRA
Biomerica IncKey Statistics
About Biomerica Inc
Biomerica Inc. (Ticker: BMRA) is a forward-thinking biotechnology firm dedicated to developing and manufacturing advanced diagnostic solutions across medical and food industries. The company focuses on proprietary testing methods targeting metabolic diseases, gastrointestinal disorders, and food intolerances, aiming to enhance healthcare outcomes and diagnostics accuracy. By engaging in strategic research collaborations and leveraging innovative technologies, Biomerica is strategically positioned to address significant unmet medical needs while capitalizing on growth opportunities within the dynamic diagnostics market. Its commitment to a patient-centric approach underscores its potential to drive transformative changes in global healthcare diagnostics.
Fundamentals
| Revenue (TTM) | $4.33M |
| Gross Profit (TTM) | 189,000 |
| EBITDA | $-5.27M |
| Operating Margin | -131.50% |
| Return on Equity | -94.30% |
| Return on Assets | -54.60% |
| Revenue/Share (TTM) | $1.61 |
| Book Value | $1.09 |
| Price-to-Book | 2.29 |
| Price-to-Sales (TTM) | 1.78 |
| EV/Revenue | 1.491 |
| EV/EBITDA | -5.42 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -11.80% |
| Shares Outstanding | $3.09M |
| Float | $2.77M |
| % Insiders | 15.24% |
| % Institutions | 3.62% |
Historical Volatility
Volatility is currently expanding